Proxy Results (Form 8-K)

On June 17, 2026, Annovis Bio, Inc. (the "Company") held its 2026 Annual Meeting of Stockholders (the "Annual Meeting") virtually. At the Annual Meeting, five proposals were submitted to the Company's stockholders and all matters voted upon were approved with the required votes. The proposals are outlined below and further described in the Company's definitive proxy statement filed with the U.S. Securities and Exchange Commission on April 30, 2026.

At the Annual Meeting, a total of 21,705,113 shares of the Company's common stock, or 62.65% of the common stock outstanding as of April 28, 2026, the record date for the Annual Meeting, were represented virtually or by proxy.

The following is a brief description of the final voting results for each of the five proposals submitted at the Annual Meeting on June 17, 2026:

1. Election of Directors

All of the following five nominees were elected to the Company's Board of Directors, in accordance with the voting results listed below, to serve for a term of one year, until the next Annual Meeting and until their successors have been duly elected and have qualified.

2. Ratification of the Company's Independent Auditors

The ratification of the appointment of Ernst & Young LLP was approved by stockholders by the following vote:

3. Amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan

The amendment to the Annovis Bio, Inc. 2019 Equity Incentive Plan to increase the number of shares that may be issued under the Plan from 4,000,000 to 5,500,000 and to increase the maximum number of shares that may be awarded in any one year from 400,000 to 600,000 shares, was approved by stockholders by the following vote:

4. ADVISORY (NON-BINDING) VOTE ON THE COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS

The compensation of the Company's named executive officers was approved by the stockholders on an advisory (non-binding basis), by the following vote:

Broker Non-Vote

5. ADVISORY (NON-BINDING) VOTE ON THE PREFERRED FREQUENCY OF FUTURE ADVISORY VOTES ON COMPENSATION OF THE COMPANY'S NAMED EXECUTIVE OFFICERS

"TWO YEARS" as the preferred frequency on the compensation of the Company's named executive officers was approved by stockholders on an advisory (non-binding basis), by the following vote:

(d) In light of this vote, and consistent with the recommendation of the Board of Directors, the Company has determined that it will include a stockholder advisory vote on executive compensation in its proxy materials every two years until the next required advisory vote on the frequency of such votes occurs, or until the Board of Directors otherwise determines a different frequency for such votes.